Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
about
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic strokeInter-rater reliability of modified Alberta Stroke program early computerized tomography score in patients with brain infarction.Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta-analysis of 19 Studies.
P2860
Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Frequency and predictors of sy ...... vator outside clinical trials.
@en
Frequency and predictors of sy ...... vator outside clinical trials.
@nl
type
label
Frequency and predictors of sy ...... vator outside clinical trials.
@en
Frequency and predictors of sy ...... vator outside clinical trials.
@nl
prefLabel
Frequency and predictors of sy ...... vator outside clinical trials.
@en
Frequency and predictors of sy ...... vator outside clinical trials.
@nl
P2093
P50
P356
P1476
Frequency and predictors of sy ...... ivator outside clinical trials
@en
P2093
Dolores Cocho
Jaume Roquer
Josep-Lluis Martí-Vilalta
José Maestre
Miguel Blanco
Mónica Millán
Víctor Obach
Yolanda Bravo
P356
10.1159/000097043
P577
2006-11-15T00:00:00Z